Patents by Inventor Huiling Wu

Huiling Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEMICONDUCTOR DEVICE HAVING CONTACT FEATURE AND METHOD OF FABRICATING THE SAME
    Publication number: 20220238661
    Abstract: A method including providing a device including a gate structure and a source/drain feature adjacent to the gate structure. An insulating layer (e.g., CESL, ILD) is formed over the source/drain feature. A trench is etched in the insulating layer to expose a surface of the source/drain feature. A semiconductor material is then formed in the etched trench on the surface of the source/drain feature. The semiconductor material is converted to a silicide.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Inventors: Xusheng WU, Chang-Miao LIU, Ying-Keung LEUNG, Huiling SHANG, Youbo LIN
  • POLYPEPTIDE DERIVATIVE AND PREPARATION METHOD THEREOF
    Publication number: 20220211857
    Abstract: Provided are a polypeptide derivative and a preparation method thereof. Specifically, a polypeptide derivative is provided. Experimental results show that the polypeptide derivative has a significantly prolonged half-life while maintaining biological activity. The preparation method of the polypeptide derivative and its use in therapy are also disclosed.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 7, 2022
    Inventors: Zhenshan ZHANG, Song WU, Huiling LIU, Wei CHEN
  • ANTIBODIES BINDING TO HUMAN IL-4R, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20210206861
    Abstract: Disclosed are antibodies binding to human IL-4R, having identical variable regions and different constant regions, wherein the variable regions can specifically bind to human IL-4R, and the constant regions affect the activity of the whole antibody through an amino acid site mutation. The above-mentioned antibodies can be used to treat diseases related to IL-4R overexpression, such as atopic dermatitis, asthma, etc., and thus possesses good clinical application prospects.
    Type: Application
    Filed: August 20, 2019
    Publication date: July 8, 2021
    Inventors: Jie ZHAO, Liangfeng JIANG, Chen CHEN, Huiling WU, Yuping HUANG, Haomin HUANG, Zhenping ZHU
  • Vaccine and uses thereof
    Publication number: 20150132302
    Abstract: The present disclosure provides immunogenic compositions, such as vaccines, including DNA vaccines, and uses thereof, e.g., to suppress or prevent an immune response and/or to treat or prevent an autoimmune disease.
    Type: Application
    Filed: May 1, 2013
    Publication date: May 14, 2015
    Inventors: Stephen Alexander, Yuan Min Wang, Guoping Zheng, Huiling Wu, David Charles Hamlyn Harris, Yiping Wang
  • Treatment for renal disease
    Publication number: 20060194752
    Abstract: Methods for treating or preventing renal disease or inducing passive immunity against renal disease by administering polynucleotides encoding MCP-1 or both MCP-1 and RANTES are provided. Compositions containing polynucleotides encoding MCP-1 or both MCP-1 and RANTES are also provided.
    Type: Application
    Filed: June 7, 2005
    Publication date: August 31, 2006
    Applicant: The Children's Hospital at Westmead Sydney West Area Health Service
    Inventors: Stephen Alexander, David Harris, Yiping Wang, Huiling Wu, Guoping Zheng